T4H-23308-50422 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-27
Dose 1 — Pfizer-BioNTech
2021-04-14
Registered in v-safe
2021-04-14
Survey response — day 14, dose 1
MedDRA: Heavy menstrual bleeding, Polymenorrhoea — Feeling: Good

Free text: Shortened menstrual cycle (week shorter than usual) and heavy period

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-17
Dose 2 — Pfizer-BioNTech
2021-04-17
Health check-in — day 0, dose 2
Feeling: Good · Fatigue or tiredness

Adult check-in
2021-04-19
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-04-21
Health check-in — days 1–6 daily, dose 2
Feeling: Poor · Headache · Be unable to do your normal daily activities

Adult check-in
2021-04-22
Survey response — days 1–6 daily, dose 2
MedDRA: Migraine — Feeling: Fair · Headache, Nausea · Be unable to do your normal daily activities

Free text: Migraine

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-23
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-04-24
Survey response — day 7, dose 2
MedDRA: Migraine — Feeling: Fair · Headache

Free text: Migraine

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-01
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-05-08
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-05-15
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-05-22
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-05-29
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-07-17
Health check-in — 3 months, dose 2
Feeling: Fair

Adult check-in
2021-10-16
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2022-04-17
Survey response — 12 months, dose 2
MedDRA: Malignant melanoma — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit

Free text: Diagnosed with melanoma

MedDRA releases: 2024-11 · check-in free text available
2022-04-17
Report sent to call center — 12 months, dose 2
Get care from a doctor or other healthcare professional

Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-04-21
Call successful
Does not wish to fill out VAERS report

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-27	Pfizer-BioNTech
2	2021-04-17	Pfizer-BioNTech

Call center

1 call center case

1 successful

See the call center timeline

Free text

Release 7 — day 14, dose 1

2021-04-14

Symptoms: Shortened menstrual cycle (week shorter than usual) and heavy period

Release 7 — days 1–6 daily, dose 2

2021-04-22

Systemic reaction (other): Migraine

Release 7 — day 7, dose 2

2021-04-24

Systemic reaction (other): Migraine

Release 11 — 12 months, dose 2

2022-04-17

Symptoms: Diagnosed with melanoma

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Heavy menstrual bleeding	✓	✓	✓
SD	Malignant melanoma	·	·	✓
SD	Polymenorrhoea	✓	✓	✓
SRO	Migraine	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release